GP2013 Treatment in Patients With Active Rheumatoid Arthritis, Previously Treated With Rituxan® or MabThera®

Clinical trial NCT02514772 · COMPLETED

Trial details

NCT number: NCT02514772
Sponsor: Sandoz
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Rheumatoid Arthritis

Start date: 2015-07-01
Primary completion: 2016-07-01
Enrollment: 107

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.